Think GLP-1s Are Too Expensive for Your Health Plan? Cutting Them Might Hurt Your Bottom Line

MAP Verified Summary — reported by Inc.

A new study reveals that dropping coverage for weight-loss drugs like Ozempic could backfire—costing companies up to $866 per worker in lost productivity.

This story was scored across MAP’s five-signal verification framework — Context, Presentation, References, Visibility, and Comparison — as part of Media Alert Press’s independent media credibility index. Read the full original story at Inc. →